{"id":"https://genegraph.clinicalgenome.org/r/6b54fb13-4f4c-4794-a643-96396ea05adfv1.0","type":"EvidenceStrengthAssertion","dc:description":"NR2F2 was first reported in relation to autosomal dominant multiple congenital anomalies/dysmorphic syndrome-NR2F2 in 2014 (Al Turk et al., PMID:24702954). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in the molecular mechanisms,  and phenotypic variability. Therefore, the following disease entities have been split into separate entities: 46XX sex reversal 5 (OMIM:618901), Congenital heart defects, multiple types, 4 (OMIM: 615779). Nine unique variants (missense, nonsense, frameshift, splice acceptor) and seven of which were de novo that have been reported in ten probands in five publications (PMIDs: 24702954, 27363585, 29663647, 29222010, 37500725) are included in this curation.Two of the variants were found to segregated respectively in two separate families (PMID:24702954, 29222010). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by a mouse model, and  expression data (PMIDs: 10215630, 24702954). In summary, NR2F2 is definitively associated with autosomal dominant multiple congenital anomalies/dysmorphic syndrome-NR2F2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 8/1/2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/6b54fb13-4f4c-4794-a643-96396ea05adf","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2bac9024-04eb-4cea-8886-3181c948e54b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2bac9024-04eb-4cea-8886-3181c948e54b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2023-08-01T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/2bac9024-04eb-4cea-8886-3181c948e54b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2024-01-08T17:02:40.293Z","role":"Publisher"}],"curationReasons":["DiseaseNameUpdate"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bac9024-04eb-4cea-8886-3181c948e54b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98c3b998-5fa3-420b-b09d-a15cd30aee87","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98c3b998-5fa3-420b-b09d-a15cd30aee87_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37500725","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c9336be-3dbe-4cd9-9bcc-6a3ced0bdea6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.746G>A (p.Trp249Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393931081"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2bac9024-04eb-4cea-8886-3181c948e54b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dd376af-8d2b-41ce-b18a-89075dc620fe_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29222010","rdfs:label":"Qiao_Han Chinese family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/3dd376af-8d2b-41ce-b18a-89075dc620fe","type":"Family","rdfs:label":"Qiao_Han Chinese family","member":{"id":"https://genegraph.clinicalgenome.org/r/e8b07214-faa0-4205-a2d3-bbe5c7744921","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29222010","rdfs:label":"Qiao_Han Chinese family_Proband II-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/ea4baa99-9cb3-4fee-85a3-63f5c1a8906f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.247G>T (p.Gly83Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393929923"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001629","obo:HP_0001719"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2c55ef28-fb85-47be-8b4a-691a51ae1597_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29222010","allele":{"id":"https://genegraph.clinicalgenome.org/r/ea4baa99-9cb3-4fee-85a3-63f5c1a8906f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"phenotypeNegativeAlleleNegative":10,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001629","obo:HP_0001719"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e8b07214-faa0-4205-a2d3-bbe5c7744921"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/f34694ca-e146-43fa-8caf-2b4ed7ae24db_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24702954","rdfs:label":"Al Turki_ Family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/f34694ca-e146-43fa-8caf-2b4ed7ae24db","type":"Family","rdfs:label":"Al Turki_ Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/d2a354a3-c5a7-4ca4-85b0-4f7efa669b70","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24702954","rdfs:label":"Al Turki_ Family 1 Individual 1 ","allele":{"id":"https://genegraph.clinicalgenome.org/r/842fe9a5-808d-4233-b1f7-f29b26adabab","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.222_224dup (p.Gln75_His76insGln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA151542"}},"firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0006695","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e0e094d7-2307-4877-9490-b6e984e117d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24702954","allele":{"id":"https://genegraph.clinicalgenome.org/r/842fe9a5-808d-4233-b1f7-f29b26adabab"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001650","obo:HP_0001636","obo:HP_0001629","obo:HP_0006695"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d2a354a3-c5a7-4ca4-85b0-4f7efa669b70"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/06116d77-21ef-4388-9f54-50b7c6298ea8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06116d77-21ef-4388-9f54-50b7c6298ea8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27363585","allele":{"id":"https://genegraph.clinicalgenome.org/r/6146afc6-e11d-4c84-a810-7c19f97c9673","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.97_103del (p.Pro33AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139664179"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/936cd3ae-6d62-4672-b9c6-dcf70877a3d7","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/936cd3ae-6d62-4672-b9c6-dcf70877a3d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37500725","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b89053d-3844-4db8-85bb-e6c0a791e0a9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.1133_1134dup (p.Glu379Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2570647"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e0e094d7-2307-4877-9490-b6e984e117d7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0e094d7-2307-4877-9490-b6e984e117d7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in cotransfected HEK293 cells using the NGFIA (128990) upstream region showed a 13% increase in transcriptional activity with the mutant compared to wildtype; there was no difference observed when the APOB","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e0e094d7-2307-4877-9490-b6e984e117d7_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2c55ef28-fb85-47be-8b4a-691a51ae1597","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c55ef28-fb85-47be-8b4a-691a51ae1597_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in HEK293 cells showed a lack of transcriptional activation with the mutant compared to wildtype NR2F2. In addition, the mutant abrogated synergistic transactivation between NR2F2 and GATA4","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2c55ef28-fb85-47be-8b4a-691a51ae1597_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6a5c2048-dd85-4e62-8921-2c0a0c71556d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a5c2048-dd85-4e62-8921-2c0a0c71556d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37500725","allele":{"id":"https://genegraph.clinicalgenome.org/r/f12f9e8c-01c4-4d7f-bc82-fa82c6691da8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.1022C>A (p.Ser341Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA151538"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/30223d87-1f28-4063-9791-c0012167e955","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30223d87-1f28-4063-9791-c0012167e955_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24702954","allele":{"id":"https://genegraph.clinicalgenome.org/r/b0c1f81e-f694-4e6b-9824-13f67492e1d8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.970+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA151544"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ca7d744c-6281-41a5-a575-7de889dbd929","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca7d744c-6281-41a5-a575-7de889dbd929_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in cotransfected HEK293 cells using the NGFIA (128990) and APOB (107730) upstream regions showed a 15% increase and an almost 30% decrease in transcriptional activity, respectively, compared to wildtype","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ca7d744c-6281-41a5-a575-7de889dbd929_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24702954","allele":{"id":"https://genegraph.clinicalgenome.org/r/c7862adc-0f85-441f-98a0-bf78a432b192","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.614A>T (p.Asn205Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA151540"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dcd33dc6-a8ae-4af8-8d67-69b7754d9d88","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcd33dc6-a8ae-4af8-8d67-69b7754d9d88_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis using 2 different promoters in cotransfected HEK293 cells showed a 20 to 52% reduction in transcriptional activity with the mutant compared to wildtype","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/dcd33dc6-a8ae-4af8-8d67-69b7754d9d88_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24702954","allele":{"id":"https://genegraph.clinicalgenome.org/r/f12f9e8c-01c4-4d7f-bc82-fa82c6691da8"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1ecf8733-f801-4d58-b500-e8b5f98a24cf","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ecf8733-f801-4d58-b500-e8b5f98a24cf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29663647","allele":{"id":"https://genegraph.clinicalgenome.org/r/df36721a-02ba-4dd6-bad5-8b10f9fa5809","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021005.4(NR2F2):c.856dup (p.Val286GlyfsTer23)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10603492"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/2bac9024-04eb-4cea-8886-3181c948e54b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bac9024-04eb-4cea-8886-3181c948e54b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4013b2f-0b62-4a97-8f42-3279b98e8283","type":"EvidenceLine","dc:description":"The model did not recapitulate the inheritance of the disease found in humans. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6545be32-e782-4a59-8a3b-9e1fe360abd0","type":"Finding","dc:description":"Targeted deletion of the COUP-TFII gene results in embryonic lethality with defects in angiogenesis and heart development. COUP-TFII mutants are defective in remodeling the primitive capillary plexus into large and small microcapillaries. In the COUP-TFII mutant heart, the atria and sinus venosus fail to develop past the primitive tube stage","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10215630","rdfs:label":"Defects in development of common atrium and sinus venosus","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2bac9024-04eb-4cea-8886-3181c948e54b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3944442b-8b69-4936-b0bb-b34c21b812a7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03206659-c74a-4a9f-aeab-995980ee853c","type":"Finding","dc:description":"Whole-mount in situ hybridization and optical projection tomography to map the pattern of Nr2f2 mRNA expression in the developing mouse embryo and observed expression in the atria of the heart, branchial arches, somites, and olfactory placode at 10.5 days postcoitum. In addition, they demonstrated expression of NR2F2 in several structures of the developing human fetal heart, including the atria, coronary vessels, and aorta","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24702954","rdfs:label":"Nr2f2 Expression in the Developing Mouse Embryo","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Definitive","sequence":7399,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/cuD1IedvMIQ","type":"GeneValidityProposition","disease":"obo:MONDO_0800458","gene":"hgnc:7976","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2bac9024-04eb-4cea-8886-3181c948e54b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}